Vedi metadata

Dati del DOI

10.3280/RSC2014-002003

Articolo

Cite as

Dati della rivista
Dati del fascicolo
Dati dell'articolo
Elenco citazioni del 10.3280/RSC2014-002003

Citazione non strutturata

Álvarez E., Viñas F. (2010). Mirtazapine in combination. Actas Españolas de Psiquiatría, 38(2): 121-8.

Citazione non strutturata

Balwin D.S. (2001). Depression and sexual dysfunction. British Medical Bulletin, 57: 81-99.

https://doi.org/10.1093/bmb/57.1.81

Citazione non strutturata

Baldwin D., Bridgman K., Buis C. (2006). Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. Journal of Psychopharmacology, 20(1): 91-6.

https://doi.org/10.1177/0269881105056666

Citazione non strutturata

Balon R., Segraves R.T., Clayton A. (2007). Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions. The American Journal of Psychiatry, 164: 198-200.

https://doi.org/10.1176/ajp.2007.164.2.198

Citazione non strutturata

Behnke K., Sogaard J., Martin S., Baüml J., Ravindran A.V., Agren H., Vester-Blokland E.D. (2003). Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Journal of Clinical Psychopharmacology, 23: 358-364.

https://doi.org/10.1097/01.jcp.0000085408.08426.05

Citazione non strutturata

Boyarsky B.K., Hirschfeld R.M. (2000). The managment of medication-induced sexual dysfunction. Essential Psychopharmacology, 3:39-58.

Citazione non strutturata

Clayton A.H., Pradko J.F., Croft H.A., Montano C.B., Leadbetter R.A., Bolden-Watson C., Bass K.L., Donahue R.M., Jamerson B.D., Mets A. (2002). Prevalence of sexual dysfunction among newer antidepressants. The Journal of clinical psychiatry, 63(4): 357-66.

https://doi.org/10.4088/JCP.v63n0414

Citazione non strutturata

Clayton A.H., Montejo A.L. (2006). Major depressive disorder, antidepressants, and sexual dysfunction. The Journal of Clinical Psychiatry, 6:33-7.

Citazione non strutturata

Clayton A., Keller A., McGrvey E. (2006). Burden of phase-specific sexual dysfunction with SSRIs. Journal of affective disorders, 91: 27-32.

https://doi.org/10.1016/j.jad.2005.12.007

Citazione non strutturata

Corretti G., Pierucci S., De Scisciolo M., Nisita C. (2006). Comorbidity between social phobia and premature ejaculation: study on 242 males affected by sexual disordres. Journal of Sex and Marital Therapy, 32: 183-187.

https://doi.org/10.1080/00926230500442342

Citazione non strutturata

Dèttore D. (2001). Psicologia e psicopatologia del comportamento sessuale. Milano: McGraw-Hill.

Citazione non strutturata

Dobkin R.D., Menza M., Marin H., Allen L.A., Rousso R., Leiblum S.R. (2006). Bupropion improves sexual functioning in depressed minority women: an open-label switch study. Journal of Clinical Psychopharmacology, 26: 21-26.

Citazione non strutturata

Galecki P., Florkowski A. (2010). Effectiveness of trazodone in the treatment of sexual dysfunctions. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, 29(169): 66-9.

Citazione non strutturata

Galecki P., Depko A., Wo􀄨niak A., Talarowska M. (2011). Depressive disorde, treatment and sexual dysfunction part II. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, 31(184): 256-9.

Citazione non strutturata

Gartlehener G., Hansen R.A., Morgan L.C., Thaler K., Lux L.J., Van Noord M., Mager U., Gaynes B.N., Thieda P., Strobelberger M., Lloyd S., Reichenpfader U., Lohr K.N. (2011). Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US), Report No: 12-EHC012-EF. AHRQ Comparative Effectiveness Reviews.

Citazione non strutturata

Graf H., Walter M., Metzger C.D., Abler B. (2013). Antidepressant-related sexual dysfunction – Perspectives from neuroimaging. Pharmacology, Biochemistry and Behavior. DOI.org./

https://doi.org/10.1016/j.pbb.2013.12.003.

Citazione non strutturata

Gregorian R.S., Golden K.A., Bahce A., Goodman C., Kwong W.J., Khan Z.M. (2002). Antidepressant-induced sexual dysfunction. The Annals of Pharmacotherapy, 36: 1557-1589.

https://doi.org/10.1345/aph.1A195

Citazione non strutturata

Harrison W.M., Rabkin J.G., Ehrhardt A.A., Stewart J.W., McGrath P.J., Ross D., Quitkin F.M. (1986). Effects of antidepressant medication on sexual function: a controlled study. Journal of Clinical Psychopharmacology, 6: 144-149.

https://doi.org/10.1097/00004714-198606000-00004

Citazione non strutturata

Hu X., Bull S., Hunkeler E., Ming E., Lee J., Fireman B., Markson L.E. (2004).

Citazione non strutturata

Incidence and duration of side effects and those rated as bothersome with selective serotonine reuptake inibitor treatment for depression. The Journal of Clinical Psychiatry, 65: 959-965.

https://doi.org/10.4088/JCP.v65n0712

Citazione non strutturata

2012.0751.

Citazione non strutturata

Kaplan H.I., Sadock B.J. (1996). Pocket Handbook of Psychiatric Drug Treatment. Baltimore: Williams & Wilkins (trad. It.: Farmaci in Psichiatria. Pocket Handbook. Torino: Centro Scientifico Internazionale srl, 1997).

Citazione non strutturata

Kennedy S.H., Eisfeld B.S., Dickens S.E., Bacchiochi J.R., Bagby R.M. (2000). Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. The Journal of Clinical Psychiatry. 61: 276-28.

https://doi.org/10.4088/JCP.v61n0406

Citazione non strutturata

Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289:3095-3105.

https://doi.org/10.1001/jama.289.23.3095

Citazione non strutturata

Kinzl J.F. (2009). Major depressive disorder, antidepressants and sexual dysfunction. Neuropsychiatrie: Klinik, Diagnostik, Thérapie und Rehabilitation: Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater, 23(2): 134-8.

Citazione non strutturata

Langworth S., Bodlund o., Agren H. (2006). Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. Journal of Clinical Psychopharmacology, 26(2): 121-7.

https://doi.org/10.1097/01.jcp.0000204138.20417.c3

Citazione non strutturata

6109.2012.02796.x.

Citazione non strutturata

Lin C.F., Juang Y.Y., Wen J.K., Liu C.Y., Hung C.I. (2012). Correlation between sexual dysfunction, depression, anxiety, and somatic symptoms among patients with major depressive disorder. Chang Gung medical journal, 35(4): 323.31.

https://doi.org/10.4103/2319-4170.106138

Citazione non strutturata

Margolese H.C., Assalian P. (1996). Sexual side effects of antidepressants: a review.Journal of sex and marital therapy, 22: 209-217.

https://doi.org/10.1080/00926239608414658

Citazione non strutturata

Martin-Du P.R., Baumann P. (2008). Sexual dysfunctions induced by antadepressants and antipsychotics. Revue médicale suisse, 4(150): 758-62.

Citazione non strutturata

Masiran R., Sidi H., Mohamed Z., Mohd Nazree N.E., Nik Jaafar N.R., Midin M., Das S., Mohamed Saini S. (2014). Female sexual dysfunction in patients with Major Depressive Disorder (MDD) treated with Selective Serotonine Reuptake Inhibitor (SSRI) and its association with Serotonine 2A-1438 G/A Single Nucleotide

https://doi.org/10.1111/jsm.12452

Citazione non strutturata

Millan M.J. (2005). Serotonine 5-HT2C receptors as a target for the treatment of depressive and anxious state: focus on novel therapeutic strategies. Thérapie, 60(5): 441-60.

https://doi.org/10.2515/therapie:2005065

Citazione non strutturata

Modabbemia A., Sohrabi H., Nasehi A.A., Raisi F., Saroukhani S., Jamshidi A., Tabrizi M., Ashafi M., Akhondzadeh S. (2012). Effect of saffron on fluoxetineinduced sexual impairment in men: randomized double-blind placebo controlled trial. Psychopharmacology, 223(4): 381-8.

https://doi.org/10.1007/s00213-012-2729-6

Citazione non strutturata

Modell J.G., Katholi C.R., Modell J.D., De Palma R.L. (1997). Comparative se side effects of bupropion, fluoxetine, paroxetine and sertraline. Clinical Pharmacology and Therapeutics, 61: 476-487.

https://doi.org/10.1016/S0009-9236(97)90198-3

Citazione non strutturata

Montejo A., Liorca G., Izquierdo J., Ledesma A., Bousoño M., Calcedo A., Carrasco J.L., Daniel E., de Dios A., de la Gàndara J., Derecho J., Franco M., Gòmez M.J., Macìas J.A., Martin T., Pèrez V., Sànchez J.M., Sànchez S., Vicens E. (1996). Sexual dysfunction secondary to SSRIs a comparative analysis in 308 patients. Actas luso-españolas de Neurología, Psiquiatría y Ciencias Afines, 24: 311-321.

Citazione non strutturata

Montejo A., Liorca G., Izquierdo J., Rico-Villademoros F. (2001). Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. The Journal of Clinical Psychiatry, 62(3): 10-21.

Citazione non strutturata

Musetti L., Pallanti S. (2003). Disturbi dell'umore. Depressione. In: Marazziti D., ed., Psicofarmacoterapia clinica. Roma: Giovanni Fioriti Editore, cap. 2, pp. 15-28.

Citazione non strutturata

Nelson J.C., Portera L., Leon A.C. (2005). Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine. The Journal of Clinical Psychiatry, 66(11): 1409-14.

https://doi.org/10.4088/JCP.v66n1110

Citazione non strutturata

Nutt D.J. (2002). Tolerability and safety aspects of mirtazapine. Human Psychopharmacology, 17(1): S37-41.

https://doi.org/10.1002/hup.388

Citazione non strutturata

Osvàth P., Fekete S., Vörös V., Almàsi J. (2005). Changes in sexual function in mirtazapine treatment. Primary data of a national, multicenter, prospective observational study in depressed patients. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology. 7(4): 177-86.

Citazione non strutturata

Patel K., Hellstrom W.J. (2009). Central regulation of ejaculation and therapeutic role of serotoninergic agents in premature ejaculation. Current Opinion in Investigational Drugs, 10(7): 681-90.

Citazione non strutturata

Epub 2009 Mar 18. Reichenpfader U., Gartlehener G., Morgan L.C., Greenblatt A., Nussbaumer B., Hansen R.A., Van Noord M., Lux L., Gaynes B.N. (2014). Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a sysstematic review with network metaanalysis. Drug Safety: an International Journal of Medical Toxicology and

Citazione non strutturata

Saiz-Ruiz J., Montes J.M., Ibanez A., Diaz M., Vicente F., Pelegrin C., Viñas R., Arias F., Carrasco J.L., Ferrando L. (2005). Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Human Psychopharmacology, 20(6): 435-440.

https://doi.org/10.1002/hup.706

Citazione non strutturata

Shen W.W., Sata L.S. (1983). Inhibited female orgasm resulting from psychotropic drugs. A clinical review. The Journal of Reproductive Medicine, 28(7): 497-9.

Citazione non strutturata

Shen W.W., Mallya A.R. (1983). MAOI-induced inhibited female orgasm. The American Journal of Psychiatry,140(9): 1275.

https://doi.org/10.1176/ajp.140.9.1275-a

Citazione non strutturata

Segraves R.T., Croft H., Kavoussi R., Ascher J.A., Batey S.R., Foster V.J., Bolden-Watson C., Metz A. (2001). Bupropion sustained release (SR) for the treatment of the hypoactive sexual desire disorder (HSDD) in non depressed women. Journal of Sex and Marital Therapy, 27: 303-316.

https://doi.org/10.1080/009262301750257155

Citazione non strutturata

Segraves R.T., Balon R. (2013). Antidepressant-induced sexual dysfunction in men. Pharmacology, Biochemistry and Behavior. DOI.org/

https://doi.org/10.1016/j.pbb.2013.11.003.

Citazione non strutturata

Serretti A., Chiesa A. (2010). Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento. Giornale Italiano di Psicopatologia, 16: 104-113. Serretti A., Chiesa A. (2011). Sexual side effects of pharmacological treatment of psychiatric diseases. Clinical Pharmacology and Therapeutics, 89: 142-147.

https://doi.org/10.1038/clpt.2010.70

Citazione non strutturata

Stahl S.M., Lee-Zimmerman C., Cartwright S., Morrisette D.A. (2013). Serotoninergic drugs for depression and beyond. Current Drug Targets, 14(5): 578-85.

https://doi.org/10.2174/1389450111314050007

Citazione non strutturata

Targo􀄔ski A., Prajsner A. (2012). Treatment of premature ejaculation. Wiadomo􀄞ci Lekarskie, 65(1): 44-7.

Citazione non strutturata

Zourkovà A., Hadasovà E. (2002). Relationship between CYP2D6 metabolic status and sexual dysfunction in paroxetine treatment. Journal of Sex and Marital Therapy, 28: 451-461.

https://doi.org/10.1080/00926230290001565

Citazione non strutturata

Zourkovà A., Ceskavà E., Hadasovà E., Ravcukovà B. (2007). Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. Journal of Sex and Marital Therapy, 33: 343-355.

https://doi.org/10.1080/00926230701385589